Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
European Journal of Immunology|May 6, 2003
Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagyFalk Nimmerjahn, Slavoljub Milosevic, Uta Behrends, et al.European Journal of Immunology|February 26, 2019
The thioredoxin-1 and glutathione/glutaredoxin-1 systems redundantly fuel murine B-cell development and responsesJonathan Muri, Helen Thut, Sebastian Heer, et al.European Journal of Immunology|November 25, 2003
Efficient generation and expansion of antigen-specific CD4+ T cells by recombinant influenza virusesFalk Nimmerjahn, Dieter Kobelt, Alexander Steinkasserer, et al.Plos One|October 17, 2013
Targeting c-MYC with T-cellsFlorian Helm, Thomas Kammertoens, Frank M Lehmann, et al.Cancer Research|November 4, 2010
Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivationPankaj Kumar Mandal, Manuela Schneider, Pirkko Kölle, et al.Plos One|July 6, 2007
Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapyDinesh Adhikary, Uta Behrends, Heike Boerschmann, et al.Plos Genetics|March 23, 2012
Mouse genetics suggests cell-context dependency for Myc-regulated metabolic enzymes during tumorigenesisLisa M Nilsson, Tacha Zi Plym Forshell, Sara Rimpi, et al.Journal of Virology|March 30, 2004
Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBVMartin Schlee, Tanja Krug, Olivier Gires, et al.Proceedings of the National Academy of Sciences of the United States of America|March 26, 2003
Recombination signal sequence-binding protein Jkappa alters mesodermal cell fate decisions by suppressing cardiomyogenesisTimm Schroeder, Stuart T Fraser, Minetaro Ogawa, et al.European Journal of Immunology|August 13, 2004
Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cellsJosef Mautner, Dagmar Pich, Falk Nimmerjahn, et al.Pageof 7